carvedilol has been researched along with Melanoma in 3 studies
Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recent studies suggest that the β-blocker drug carvedilol prevents skin carcinogenesis but the mechanism is unknown." | 3.88 | Phosphoproteome profiling provides insight into the mechanism of action for carvedilol-mediated cancer prevention. ( Andresen, BT; Cleveland, KH; Huang, KM; Huang, Y; Liang, S; Yeung, S, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, Q | 1 |
| Long, J | 1 |
| Hu, L | 1 |
| Chen, Z | 1 |
| Li, Q | 1 |
| Hu, G | 1 |
| Muhailan, M | 1 |
| Al-Shbool, G | 1 |
| Cleveland, KH | 1 |
| Yeung, S | 1 |
| Huang, KM | 1 |
| Liang, S | 1 |
| Andresen, BT | 1 |
| Huang, Y | 1 |
3 other studies available for carvedilol and Melanoma
| Article | Year |
|---|---|
Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Dru | 2020 |
Pseudo-Wellens' Syndrome Temporally Associated With Immune Check Point Inhibitors Use.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Antineoplast | 2020 |
Phosphoproteome profiling provides insight into the mechanism of action for carvedilol-mediated cancer prevention.
Topics: Adrenergic beta-Antagonists; Animals; Anticarcinogenic Agents; Carcinogenesis; Carvedilol; Epidermal | 2018 |